These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Troglitazone: a new antihyperglycemic agent. Vidt DG; Speerhas RA; Reddy SS Cleve Clin J Med; 1997 May; 64(5):238-40. PubMed ID: 9149473 [TBL] [Abstract][Full Text] [Related]
4. Troglitazone and small low-density lipoprotein in type 2 diabetes. Hirano T; Yoshino G; Kazumi T Ann Intern Med; 1998 Jul; 129(2):162-3. PubMed ID: 9669982 [No Abstract] [Full Text] [Related]
5. New diabetes drug targets insulin resistance. Am J Health Syst Pharm; 1997 Mar; 54(6):623, 625. PubMed ID: 9075488 [No Abstract] [Full Text] [Related]
6. Effect of troglitazone on lipoprotein(a) levels in obese subjects. Tack CJ; Smits P; DeMacker PN; Stalenhoef AF Diabetes Care; 1999 Oct; 22(10):1752-3. PubMed ID: 10526754 [No Abstract] [Full Text] [Related]
7. New directions in treating insulin resistance. Reusch JE Hosp Pract (1995); 1995 Sep; 30(9):9-10. PubMed ID: 7559840 [No Abstract] [Full Text] [Related]
8. [Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes]. Westerbacka J; Yki-Järvinen H Duodecim; 1997; 113(19):1847-8. PubMed ID: 10892078 [No Abstract] [Full Text] [Related]
9. Effect of troglitazone in type 2 diabetes mellitus. Gorson DM N Engl J Med; 1998 Aug; 339(6):406. PubMed ID: 9696655 [No Abstract] [Full Text] [Related]
10. Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin. Blonde L; Sandberg MI; Guthrie RD Diabetes Care; 1999 Jun; 22(6):1004-6. PubMed ID: 10372262 [No Abstract] [Full Text] [Related]
11. The rise and fall of troglitazone. Bailey CJ Diabet Med; 2000 Jun; 17(6):414-5. PubMed ID: 10975209 [No Abstract] [Full Text] [Related]
12. New therapeutic approaches to reversing insulin resistance. Sonnenberg GE; Kotchen TA Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):551-5. PubMed ID: 9818203 [TBL] [Abstract][Full Text] [Related]
13. Effect of troglitazone in type 2 diabetes mellitus. Rusk MH N Engl J Med; 1998 Aug; 339(6):406. PubMed ID: 9696656 [No Abstract] [Full Text] [Related]
14. International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone. Bloomgarden ZT Diabetes Care; 1998 Jun; 21(6):1024-6. PubMed ID: 9614626 [No Abstract] [Full Text] [Related]
15. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials. Krentz AJ; Bailey CJ; Melander A BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108 [No Abstract] [Full Text] [Related]